Per Larsson

1.4k total citations
34 papers, 1.1k citations indexed

About

Per Larsson is a scholar working on Surgery, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Per Larsson has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Surgery, 14 papers in Molecular Biology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Per Larsson's work include Bladder and Urothelial Cancer Treatments (19 papers), Epigenetics and DNA Methylation (10 papers) and Urinary and Genital Oncology Studies (7 papers). Per Larsson is often cited by papers focused on Bladder and Urothelial Cancer Treatments (19 papers), Epigenetics and DNA Methylation (10 papers) and Urinary and Genital Oncology Studies (7 papers). Per Larsson collaborates with scholars based in Sweden, Germany and United States. Per Larsson's co-authors include Gunnar Steineck, J. Hed, Gunnel Halldén, Sverker Johansson, Per Malmberg, Zhicheng Wang, Kari Hemminki, Jan Adolfsson, Hans Wijkström and Ulf Norming and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, The Journal of Urology and British Journal of Cancer.

In The Last Decade

Per Larsson

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Per Larsson Sweden 18 448 328 276 189 170 34 1.1k
Geneviève Paulissen Belgium 18 437 1.0× 190 0.6× 358 1.3× 497 2.6× 273 1.6× 27 1.5k
Gerhard Dekan Austria 20 376 0.8× 261 0.8× 314 1.1× 203 1.1× 325 1.9× 54 1.2k
Barbara Griffith United States 12 563 1.3× 408 1.2× 143 0.5× 231 1.2× 619 3.6× 20 1.8k
Jerome Cantor United States 22 321 0.7× 117 0.4× 818 3.0× 111 0.6× 84 0.5× 85 1.4k
Ayumi Fukuoka Japan 15 193 0.4× 159 0.5× 106 0.4× 238 1.3× 253 1.5× 28 871
Horst Nizze Germany 19 269 0.6× 355 1.1× 152 0.6× 110 0.6× 214 1.3× 56 995
Dolphine Oda United States 23 390 0.9× 284 0.9× 252 0.9× 84 0.4× 294 1.7× 58 1.3k
Najmunnisa Nasreen United States 25 390 0.9× 200 0.6× 621 2.3× 195 1.0× 163 1.0× 47 1.3k
Ludwik K. Trejdosiewicz United Kingdom 16 472 1.1× 468 1.4× 73 0.3× 247 1.3× 155 0.9× 29 1.2k
Masayuki Kitajima Japan 16 313 0.7× 162 0.5× 122 0.4× 482 2.6× 175 1.0× 65 1.3k

Countries citing papers authored by Per Larsson

Since Specialization
Citations

This map shows the geographic impact of Per Larsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Per Larsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Per Larsson more than expected).

Fields of papers citing papers by Per Larsson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Per Larsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Per Larsson. The network helps show where Per Larsson may publish in the future.

Co-authorship network of co-authors of Per Larsson

This figure shows the co-authorship network connecting the top 25 collaborators of Per Larsson. A scholar is included among the top collaborators of Per Larsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Per Larsson. Per Larsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thorstenson, Andreas, Martin Schumacher, Peter Wiklund, et al.. (2009). Diagnostic random bladder biopsies: Reflections from a population-based cohort of 538 patients. Scandinavian Journal of Urology and Nephrology. 44(1). 11–19. 12 indexed citations
2.
Sanyal, Somali, Petra J. de Verdier, Gunnar Steineck, et al.. (2006). Polymorphisms inXPD,XPCand the risk of death in patients with urinary bladder neoplasms. Acta Oncologica. 46(1). 31–41. 32 indexed citations
3.
Sakano, Shigeru, Rajiv Kumar, Per Larsson, et al.. (2005). A single‐nucleotide polymorphism in the XPG gene, and tumour stage, grade, and clinical course in patients with nonmuscle‐invasive neoplasms of the urinary bladder. British Journal of Urology. 97(4). 847–851. 21 indexed citations
4.
Ryk, Charlotta, Rajiv Kumar, Somali Sanyal, et al.. (2005). Influence of polymorphism in DNA repair and defence genes on p53 mutations in bladder tumours. Cancer Letters. 241(1). 142–149. 38 indexed citations
5.
Ryk, Charlotta, Petra Berggren, Rajiv Kumar, et al.. (2004). Influence of GSTM1, GSTT1, GSTP1 and NAT2 genotypes on the p53 mutational spectrum in bladder tumours. International Journal of Cancer. 113(5). 761–768. 19 indexed citations
6.
Sakano, Shigeru, Petra Berggren, Rajiv Kumar, et al.. (2003). Clinical course of bladder neoplasms and single nucleotide polymorphisms in the CDKN2A gene. International Journal of Cancer. 104(1). 98–103. 29 indexed citations
7.
Mallbris, Lotus, et al.. (2003). Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-? therapy. Journal of the American Academy of Dermatology. 48(2). 290–293. 67 indexed citations
8.
Seddighzadeh, Maria, Gunnar Steineck, Per Larsson, et al.. (2002). Expression of UPA and UPAR is associated with the clinical course of urinary bladder neoplasms. International Journal of Cancer. 99(5). 721–726. 27 indexed citations
9.
Berggren, Petra, Gunnar Steineck, Jan Adolfsson, et al.. (2001). p53 mutations in urinary bladder cancer. British Journal of Cancer. 84(11). 1505–1511. 47 indexed citations
10.
Seddighzadeh, Maria, Gunnar Steineck, Olof Jansson, et al.. (2001). Low interleukin-1α messenger RNA levels predict decreased overall survival time of patients with urinary bladder carcinoma. British Journal of Cancer. 84(3). 329–334. 13 indexed citations
11.
Larsson, Per. (2001). Allelic deletion fingerprinting of urine cell sediments in bladder cancer. Molecular Diagnosis. 6(3). 181–188. 8 indexed citations
12.
Larsson, Per, Ulf Norming, Magnus Törnblom, & Oskar Gustafsson. (1999). Antibiotic prophylaxis for prostate biopsy: benefits and costs. Prostate Cancer and Prostatic Diseases. 2(2). 88–90. 17 indexed citations
13.
Wang, Zhicheng, Kjell Larsson, Lena Palmberg, et al.. (1997). Inhalation of swine dust induces cytokine release in the upper and lower airways. European Respiratory Journal. 10(2). 381–387. 139 indexed citations
14.
Jewett, Michael A.S. & Per Larsson. (1997). Appropriate Restaging Biopsies After Initial Resection or Topical Intravesical Therapy. 5(2). 15–22. 1 indexed citations
15.
Wang, Zhicheng, Per Malmberg, Per Larsson, Britt‐Marie Larsson, & Kristin Larsson. (1996). Time Course of Interleukin-6 and Tumor Necrosis Factor-Alpha Increase in Serum Following Inhalation of Swine Dust. American Journal of Respiratory and Critical Care Medicine. 153(1). 147–152. 60 indexed citations
16.
Larsson, Per, Göran Roos, Roger Stenling, George D. Wilson, & Börje Ljungberg. (1996). Cell proliferation in renal cell carcinoma ? a comparative study of cell kinetic methods. Urological Research. 24(5). 291–295. 4 indexed citations
17.
Larsson, Per, Börje Ljungberg, Göran Roos, & Roger Stenling. (1993). Tumor‐cell proliferation and prognosis in renal‐cell carcinoma. International Journal of Cancer. 55(4). 566–570. 29 indexed citations
18.
Ljungberg, Börje, Per Larsson, Roger Stenling, & Göran Roos. (1991). Flow Cytometric Deoxyribonucleic Acid Analysis in Stage I Renal Cell Carcinoma. The Journal of Urology. 146(3). 697–699. 32 indexed citations
19.
Scheynius, Annika, et al.. (1989). Effects of Purified Protein Derivative (PPD)‐Activated Syngeneic Epidermal Cells on a PPD‐Specific Rat T‐Helper Cell Line. Scandinavian Journal of Immunology. 29(6). 671–677. 2 indexed citations
20.
Hed, J., Gunnel Halldén, Sverker Johansson, & Per Larsson. (1987). The use of fluorescence quenching in flow cytofluorometry to measure the attachment and ingestion phases in phagocytosis in peripheral blood without prior cell separation. Journal of Immunological Methods. 101(1). 119–125. 181 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Geneviève Paulissen Breakdown of academic impact, for papers by Gerhard Dekan Breakdown of academic impact, for papers by Barbara Griffith Breakdown of academic impact, for papers by Jerome Cantor Breakdown of academic impact, for papers by Ayumi Fukuoka Breakdown of academic impact, for papers by Horst Nizze Breakdown of academic impact, for papers by Dolphine Oda Breakdown of academic impact, for papers by Najmunnisa Nasreen Breakdown of academic impact, for papers by Ludwik K. Trejdosiewicz Breakdown of academic impact, for papers by Masayuki Kitajima
Rankless by CCL
2026